104 related articles for article (PubMed ID: 7756378)
1. Quality-of-life and cost-effectiveness assessment in lung cancer.
Bergman B; Aaronson NK
Curr Opin Oncol; 1995 Mar; 7(2):138-43. PubMed ID: 7756378
[TBL] [Abstract][Full Text] [Related]
2. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Hockenhull J; Proudlove C; Dundar Y; Richardson M; Dickson R; Mullard A; Marshall E
Health Technol Assess; 2015 Jun; 19(47):1-134. PubMed ID: 26134145
[TBL] [Abstract][Full Text] [Related]
3. Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapy.
Osoba D; Murray N; Gelmon K; Karsai H; Knowling M; Shah A; McLaughlin M; Fetherstonhaugh E; Page R; Bowman CA
Oncology (Williston Park); 1994 Apr; 8(4):61-5; discussion 65-6, 69. PubMed ID: 8003398
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer.
Plosker GL; Hurst M
Pharmacoeconomics; 2001; 19(11):1111-34. PubMed ID: 11735678
[TBL] [Abstract][Full Text] [Related]
5. PUREAIR protocol: randomized controlled trial of intensive pulmonary rehabilitation versus standard care in patients undergoing surgical resection for lung cancer.
Fugazzaro S; Costi S; Mainini C; Kopliku B; Rapicetta C; Piro R; Bardelli R; Rebelo PFS; Galeone C; Sgarbi G; Lococo F; Paci M; Ricchetti T; Cavuto S; Merlo DF; Tenconi S
BMC Cancer; 2017 Jul; 17(1):508. PubMed ID: 28760151
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.
Rowland KM; Loprinzi CL; Shaw EG; Maksymiuk AW; Kuross SA; Jung SH; Kugler JW; Tschetter LK; Ghosh C; Schaefer PL; Owen D; Washburn JH; Webb TA; Mailliard JA; Jett JR
J Clin Oncol; 1996 Jan; 14(1):135-41. PubMed ID: 8558188
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
Grossi F; Tiseo M
Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
[TBL] [Abstract][Full Text] [Related]
8. The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials.
Wheatley-Price P; Le Maître A; Ding K; Leighl N; Hirsh V; Seymour L; Bezjak A; Shepherd FA;
J Thorac Oncol; 2010 May; 5(5):640-8. PubMed ID: 20354457
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials.
Zikos E; Ghislain I; Coens C; Ediebah DE; Sloan E; Quinten C; Koller M; van Meerbeeck JP; Flechtner HH; Stupp R; Pallis A; Czimbalmos A; Sprangers MA; Bottomley A
Lancet Oncol; 2014 Feb; 15(2):e78-89. PubMed ID: 24480558
[TBL] [Abstract][Full Text] [Related]
10. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?
Ganz PA; Figlin RA; Haskell CM; La Soto N; Siau J
Cancer; 1989 Apr; 63(7):1271-8. PubMed ID: 2465815
[TBL] [Abstract][Full Text] [Related]
11. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer.
Ganz PA; Haskell CM; Figlin RA; La Soto N; Siau J
Cancer; 1988 Feb; 61(4):849-56. PubMed ID: 3276389
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group.
Helsing M; Bergman B; Thaning L; Hero U
Eur J Cancer; 1998 Jun; 34(7):1036-44. PubMed ID: 9849452
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer.
Solà I; Thompson E; Subirana M; López C; Pascual A
Cochrane Database Syst Rev; 2004 Oct; (4):CD004282. PubMed ID: 15495096
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.
Spiro SG; Rudd RM; Souhami RL; Brown J; Fairlamb DJ; Gower NH; Maslove L; Milroy R; Napp V; Parmar MK; Peake MD; Stephens RJ; Thorpe H; Waller DA; West P;
Thorax; 2004 Oct; 59(10):828-36. PubMed ID: 15454647
[TBL] [Abstract][Full Text] [Related]
16. Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working Party.
Qian W; Parmar MK; Sambrook RJ; Fayers PM; Girling DJ; Stephens RJ
Stat Med; 2000 Oct; 19(19):2657-74. PubMed ID: 10986540
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.
Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A
Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561
[TBL] [Abstract][Full Text] [Related]
18. Measuring quality of life: an emerging science.
Moinpour CM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):48-60; discussion 60-3. PubMed ID: 7973770
[TBL] [Abstract][Full Text] [Related]
19. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer.
Ran J; Wang J; Bi N; Jiang W; Zhou Z; Hui Z; Liang J; Feng Q; Wang L
Radiat Oncol; 2017 Dec; 12(1):195. PubMed ID: 29197373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
